Why are East Asians more susceptible to several infection-associated cancers (carcinomas of the nasopharynx, stomach, liver, adenocarcinoma of the lung, nasal NK/T-cell lymphomas)?

Medical Hypotheses

Volumn 79, Issue 6, 2012, Pages 833-842

  Wee, J ^a,b   Nei, W L ^a   Yeoh, K W ^a   Yeo, R M ^a   Loong, S L ^a,b   Qian, C N ^c,d  

^a DIVISION OF MEDICAL ONCOLOGY   (Singapore)

^b DUKE NUS MEDICAL SCHOOL   (Singapore)

^c SUN YAT SEN UNIVERSITY CANCER CENTER   (China)

^d VAN ANDEL RESEARCH INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

TOLL LIKE RECEPTOR 8;

ARTICLE; ASIAN; CANCER INCIDENCE; EPSTEIN BARR VIRUS INFECTION; GENETIC POLYMORPHISM; HELICOBACTER INFECTION; HEPATITIS B; HIGH RISK POPULATION; HUMAN; HYPOTHESIS; INFECTION; LAST GLACIAL MAXIMUM; LIVER CELL CARCINOMA; LUNG ADENOCARCINOMA; NASOPHARYNX CANCER; NK T CELL LYMPHOMA; STOMACH CANCER;

ASIA, SOUTHEASTERN; DISEASE SUSCEPTIBILITY; FEMALE; HELICOBACTER INFECTIONS; HEPATITIS B; HERPESVIRUS 4, HUMAN; HUMANS; MODELS, THEORETICAL; NEOPLASMS; TUMOR VIRUS INFECTIONS;

HELICOBACTER PYLORI; HEPATITIS B VIRUS; HUMAN HERPESVIRUS 4;

EID: 84869086321     PISSN: 03069877     EISSN: 15322777     Source Type: Journal    
DOI: 10.1016/j.mehy.2012.09.003     Document Type: Article

References (106)

1. Wee J.T., Ha T.C., Loong S.L., Qian C.N. Is nasopharyngeal cancer really a "Cantonese cancer" ?. Chin J Cancer 2010, 29(5):517-526.
2. Li H., Wen B., Chen S.J., et al. Paternal genetic affinity between Western Austronesians and Daic populations. BMC Evol Biol 2008, 15(8):146.
3. Trejaut J., Lee C.L., Yen J.C., Loo J.H., Lin M. Ancient migration routes of Austronesian-speaking populations in oceanic Southeast Asia and Melanesia might mimic the spread of nasopharyngeal carcinoma. Chin J Cancer 2011, 30(2):96-105.
4. Jinam T.A., Hong L.C., Phipps M.E., Stoneking M., Ameen M. The Pan-Asian SNP Consortium, Saitou N. Evolutionary history of continental South East Asians: "early train" hypothesis based on genetic analysis of mitochondrial and autosomal DNA data. Mol Biol Evol 2012, [Epub ahead of print].
5. Wen B., Li H., Lu D., et al. Genetic evidence supports demic diffusion of Han culture. Nature 2004, 431(7006):302-305.
6. Jin L. Personal communications. In: Presentation at NPC seminar. Singapore: 2009.
7. Jordan F.M., Gray R.D., Greenhill S.J., Mace R. Matrilocal residence is ancestral in Austronesian societies. Proc Biol Sci 2009, 276(1664):1957-1964. [Epub 2009 Mar 4].
8. Lu S.J., Day N.E., Degos L., et al. Linkage of a nasopharyngeal carcinoma susceptibility locus to the HLA region. Nature 1990, 346(6283):470-471.
9. Hu S.P., Day N.E., Li D.R., et al. Further evidence for an HLA-related recessive mutation in nasopharyngeal carcinoma among the Chinese. Br J Cancer 2005, 92(5):967-970.
10. Simons M.J. Nasopharyngeal carcinoma as a paradigm of cancer genetics. Chin J Cancer 2011, 30(2):79-84.
11. Bei J.X., Li Y., Jia W.H., et al. A genome-wide association study of nasopharyngeal carcinoma identifies three new susceptibility loci. Nat Genet 2010, 42(7):599-603. [Epub 2010 May 30].
12. Tse K.P., Su W.H., Chang K.P., et al. Genome-wide association study reveals multiple nasopharyngeal carcinoma-associated loci within the HLA region at chromosome 6p21.3. Am J Hum Genet 2009, 85(2):194-203. [Epub 2009 Aug 6].
13. Ng C.C., Yew P.Y., Puah S.M., et al. A genome-wide association study identifies ITGA9 conferring risk of nasopharyngeal carcinoma. J Hum Genet 2009, 54(7):392-397. [Epub 2009 May 29].
14. Pathmanathan R., Prasad U., Sadler R., Flynn K., Raab-Traub N. Clonal proliferations of cells infected with Epstein-Barr virus in preinvasive lesions related to nasopharyngeal carcinoma. N Engl J Med 1995, 333(11):693-698.
15. Zhong B.L., Zong Y.S., Lin S.X., Zhang M., Liang Y.J. Epstein-Barr virus infection in precursor lesions of nasopharyngeal carcinoma. Ai Zheng 2006, 25(2):136-142.
16. Hjalgrim H., Rostgaard K., Johnson P.C., et al. HLA-A alleles and infectious mononucleosis suggest a critical role for cytotoxic T-cell response in EBV-related Hodgkin lymphoma. Proc Natl Acad Sci USA 2010, 107(14):6400-6405. [Epub 2010 Mar 22].
17. Cheng P.L., Eng H.L., Chou M.H., You H.L., Lin T.M. Genetic polymorphisms of viral infection-associated Toll-like receptors in Chinese population. Transl Res 2007, 150(5):311-318. [Epub 2007 May 25].
18. Lesmeister M.J., Bothwell M.R., Misfeldt M.L. Toll-like receptor expression in the human nasopharyngeal tonsil (adenoid) and palantine tonsils: a preliminary report. Int J Pediatr Otorhinolaryngol 2006, 70(6):987-992. [Epub 2005 Dec 2].
19. Davila S., Hibberd M.L., Hari Dass R., et al. Genetic association and expression studies indicate a role of Toll-like receptor 8 in pulmonary tuberculosis. PLoS Genet 2008, 4(10):e1000218. [Epub 2008 Oct 10].
20. WHO Global tuberculosis control 2009: epidemiology, strategy, financing 2009, WHO, Geneva, Available .
21. Qing Liu. Complex segregation analysis of 147 nasopharyngeal carcinoma (Npc) pedigrees in Sihui City, PR China. UICC World Cancer Congress 2006, July 8-12, Washington, DC, USA: 2006.
22. Lee A.W., Lau W.H., Tung S.Y., et al. Preliminary results of a randomized study on therapeutic gain by concurrent chemotherapy for regionally-advanced nasopharyngeal carcinoma: NPC-9901 Trial by the Hong Kong Nasopharyngeal Cancer Study Group. J Clin Oncol 2005, 23(28):6966-6975. Hong Kong Nasopharyngeal Cancer Study Group.
23. Wu C.Y., Hu H.Y., Pu C.Y., et al. Aerodigestive tract, lung and haematological cancers are risk factors for tuberculosis: an 8-year population-based study. Int J Tuberc Lung Dis 2011, 15(1):125-130.
24. Rakoff-Nahoum S., Medzhitov R. Toll-like receptors and cancer. Nat Rev Cancer 2009, 9(1):57-63. [Epub 2008 Dec 4. Review].
25. Young L.S., Rickinson A.B. Epstein-Barr virus: 40years on. Nat Rev Cancer 2004, 4(10):757-768. [Review].
26. Heil F., Hemmi H., Hochrein H., et al. Species-specific recognition of single-stranded RNA via Toll-like receptors 7 and 8. Science 2004, 303(5663):1526-1529. [Epub 2004 Feb 19].
27. Younesi V., Nikzamir H., Yousefi M., et al. Epstein Barr virus inhibits the stimulatory effect of TLR7/8 and TLR9 agonists but not CD40 ligand in human B lymphocytes. Microbiol Immunol 2010, 54(9):534-541.
28. Wong B.C., Lam S.K., Ching C.K., et al. Differential Helicobacter pylori infection rates in two contrasting gastric cancer risk regions of South China. J Gastroenterol Hepatol 1999, 14(2):120-125. China Gastric Cancer Study Group.
29. Yeh J.M., Goldie S.J., Kuntz K.M., Ezzati M. Effects of Helicobacter pylori infection and smoking on gastric cancer incidence in China: a population-level analysis of trends and projections. Cancer Causes Control 2009, 20(10):2021-2029.
30. Sakakura C., Mori T., Sakabe T., et al. Gains, losses, and amplifications of genomic materials in primary gastric cancers analyzed by comparative genomic hybridization. Genes Chromosomes Cancer 1999, 24(4):299-305.
31. Goodman K.J., Jacobson K., Veldhuyzen van Zanten S. Helicobacter pylori infection in Canadian and related Arctic Aboriginal populations. Can J Gastroenterol 2008, 22(3):289-295. [Review].
32. Zeng H.M., Pan K.F., Zhang Y., et al. Genetic variants of toll-like receptor 2 and 5, Helicobacter pylori infection, and risk of gastric cancer and its precursors in a chinese population. Cancer Epidemiol Biomarkers Prev 2011, 20(12):2594-2602. [Epub 2011 Oct 12].
33. Ando T., Ishikawa T., Kato H., et al. Synergistic effect of HLA class II loci and cytokine gene polymorphisms on the risk of gastric cancer in Japanese patients with Helicobacter pylori infection. Int J Cancer 2009, 125(11):2595-2602.
34. Li Z., Chen D., Zhang C., et al. HLA polymorphisms are associated with Helicobacter pylori infected gastric cancer in a high risk population, China. Immunogenetics 2005, 56(11):781-787. [Epub 2005 Jan 14].
35. Hold G.L., Rabkin C.S., Chow W.H., et al. A functional polymorphism of Toll-like receptor 4 gene increases risk of gastric carcinoma and its precursors. Gastroenterology 2007, 132(3):905-912.
36. Ng M.T., Van't Hof R., Crockett J.C., et al. Increase in NF-kappaB binding affinity of the variant C allele of the Toll-like receptor 9-1237T/C polymorphism is associated with Helicobacter pylori-induced gastric disease. Infect Immun 2010, 78(3):1345-1352. [Epub 2009 Dec 28].
37. Gantier M.P., Irving A.T., Kaparakis-Liaskos M., et al. Genetic modulation of TLR8 response following bacterial phagocytosis. Hum Mutat 2010, 31(9):1069-1079.
38. Peng G., Guo Z., Kiniwa Y., et al. Toll-like receptor 8-mediated reversal of CD4+ regulatory T cell function. Science 2005, 309:1380-1384.
39. Perry S., de Jong B.C., Solnick J.V., et al. Infection with Helicobacter pylori is associated with protection against tuberculosis. PLoS One 2010, 5(1):e8804.
40. El-Serag H.B., Rudolph K.L. Hepatocellular carcinoma: epidemiology and molecular carcinogenesis. Gastroenterology 2007, 132(7):2557-2576. [Review].
41. Chang M.H., You S.L., Chen C.J., et al. Decreased incidence of hepatocellular carcinoma in hepatitis B vaccinees: a 20-year follow-up study. J Natl Cancer Inst 2009, 101(19):1348-1355. Taiwan Hepatoma Study Group, [Epub 2009 Sep 16].
42. Wang J.Y., Liu C.H., Hu F.C., et al. Risk factors of hepatitis during anti-tuberculous treatment and implications of hepatitis virus load. J Infect 2011, 62(6):448-455. [Epub 2011 Apr 28].
43. Wang C.H., Eng H.L., Lin K.H., et al. TLR7 and TLR8 gene variations and susceptibility to hepatitis C virus infection. PLoS One 2011, 6(10):e26235. [Epub 2011 Oct 13].
44. Shao Z.J., Zhang L., Xu J.Q., et al. Mother-to-infant transmission of hepatitis B virus: a Chinese experience. J Med Virol 2011, 83(5):791-795. [Epub 2011 Feb 25]. 10.1002/jmv.22043.
45. Wu J., Lu M., Meng Z., et al. Toll-like receptor-mediated control of HBV replication by nonparenchymal liver cells in mice. Hepatology 2007, 46(6):1769-1778.
46. Levy O., Zarember K.A., Roy R.M., Cywes C., Godowski P.J., Wessels M.R. Selective impairment of TLR-mediated innate immunity in human newborns: neonatal blood plasma reduces monocyte TNF-alpha induction by bacterial lipopeptides, lipopolysaccharide, and imiquimod, but preserves the response to R-848. J Immunol 2004, 173(7):4627-4634.
47. Shi K.Q., Cai X.H., Xiao D.D., et al. Tumour necrosis factor-α-857T allele reduces the risk of hepatitis B virus infection in an Asian population. J Viral Hepat 2012, 19(2):e66-e72. [Epub 2011 Nov 17].
48. Zheng M.H., Xiao D.D., Lin X.F., et al. The tumour necrosis factor-α-238A allele increases the risk of chronic HBV infection in European populations. J Viral Hepat 2012, 19(2):e11-e17.
49. Chen X., Zhang L., Chang Y., et al. Association of TNF-alpha genetic polymorphisms with hepatocellular carcinoma susceptibility: a case-control study in a Han Chinese population. Int J Biol Markers 2011, 26(3):181-187.
50. Tanaka E., Urata Y. Risk of hepatitis B reactivation in patients treated with tumor necrosis factor-α inhibitors. Hepatol Res 2012, 42(4):333-339.
51. Schlaepfer E., Speck R.F. TLR8 activates HIV from latently infected cells of myeloid-monocytic origin directly via the MAPK pathway and from latently infected CD4+ T cells indirectly via TNF-α. J Immunol 2011, 186(7):4314-4324. [Epub 2011 Feb 28].
52. Bendelja K., Vojvoda V., Aberle N., et al. Decreased Toll-like receptor 8 expression and lower TNF-α synthesis in infants with acute RSV infection. Respir Res 2010, 14(11):143.
53. Singh R., Kaul R., Kaul A., Khan K. A comparative review of HLA associations with hepatitis B and C viral infections across global populations. World J Gastroenterol 2007, 13(12):1770-1787. [Review].
54. Lim S.T., Wong E.H., Chuah K.L., et al. Gefitinib is more effective in never-smokers with non-small-cell lung cancer: experience among Asian patients. Br J Cancer 2005, 93(1):23-28.
55. Ho C., Murray N., Laskin J., Melosky B., Anderson H., Bebb G. Asian ethnicity and adenocarcinoma histology continues to predict response to gefitinib in patients treated for advanced non-small cell carcinoma of the lung in North America. Lung Cancer 2005, 49(2):225-231.
56. Shugart Y.Y., Wang Y., Jia W.H., Zeng Y.X. GWAS signals across the HLA regions: revealing a clue for common etiology underlying infectious tumors and other immunity diseases. Chin J Cancer 2011, 30(4):226-230.
57. Cadranel J., Garfield D., Lavolé A., Wislez M., Milleron B., Mayaud C. Lung cancer in HIV infected patients: facts, questions and challenges. Thorax 2006, 61(11):1000-1008. [Review].
58. Caporale M., Centorame P., Giovannini A., et al. Infection of lung epithelial cells and induction of pulmonary adenocarcinoma is not the most common outcome of naturally occurring JSRV infection during the commercial lifespan of sheep. Virology 2005, 338(1):144-153.
59. Murgia C., Caporale M., Ceesay O., et al. Lung adenocarcinoma originates from retrovirus infection of proliferating type 2 pneumocytes during pulmonary post-natal development or tissue repair. PLoS Pathog 2011, 7(3):e1002014. [Epub 2011 Mar 31].
60. Goto A., Li C.P., Ota S., et al. Human papillomavirus infection in lung and esophageal cancers: analysis of 485 Asian cases. J Med Virol 2011, 83(8):1383-1390. 10.1002/jmv.22150.
61. Cheng Y.W., Chiou H.L., Sheu G.T., et al. The association of human papillomavirus 16/18 infection with lung cancer among nonsmoking Taiwanese women. Cancer Res 2001, 61(7):2799-2803.
62. Baba M., Castillo A., Koriyama C., et al. Human papillomavirus is frequently detected in gefitinib-responsive lung adenocarcinomas. Oncol Rep 2010, 23(4):1085-1092.
63. Klein F., Amin Kotb W.F., Petersen I. Incidence of human papilloma virus in lung cancer. Lung Cancer 2009, 65(1):13-18. [Epub 2008 Nov 18. Review].
64. Liang H.Y., Li X.L., Yu X.S., et al. Facts and fiction of the relationship between preexisting tuberculosis and lung cancer risk: a systematic review. Int J Cancer 2009, 125(12):2936-2944. [Review].
65. Aozasa K., Takakuwa T., Hongyo T., Yang W.I. Nasal NK/T-cell lymphoma: epidemiology and pathogenesis. Int J Hematol 2008, 87(2):110-117. [Epub 2008 Feb 8. Review].
66. Siu L.L., Chan J.K., Kwong Y.L. Natural killer cell malignancies: clinicopathologic and molecular features. Histol Histopathol 2002, 17(2):539-554. [Review].
67. Huang Y., de Reyniès A., de Leval L., et al. Gene expression profiling identifies emerging oncogenic pathways operating in extranodal NK/T-cell lymphoma, nasal type. Blood 2010, 115(6):1226-1237. [Epub 2009 Nov 30].
68. Kanno H., Kojya S., Li T., et al. Low frequency of HLA-A0201 allele in patients with Epstein-Barr virus-positive nasal lymphomas with polymorphic reticulosis morphology. Int J Cancer 2000, 87(2):195-199.
69. Chetaille B., Bertucci F., Finetti P., et al. Molecular profiling of classical Hodgkin lymphoma tissues uncovers variations in the tumor microenvironment and correlations with EBV infection and outcome. Blood 2009, 113(12):2765-3775. [Epub 2008 Dec 18].
70. Urayama K.Y., Jarrett R.F., Hjalgrim H., et al. Genome-wide association study of classical hodgkin lymphoma and Epstein-Barr virus status-defined subgroups. J Natl Cancer Inst 2012, 104(3):240-253. [Epub 2012 Jan 27].
71. Yadav M.S., Malliga N., Ablashi D.V. Development of immunity to Epstein-Barr virus in Malaysian children. Microbiologica 1987, 10(1):29-35.
72. Du H.J., Zhou L., Liu H.T., et al. A serological survey of Epstein-Barr virus infection in children in Beijing. Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi 2008, 22(1):30-32. [Chinese].
73. Piriou E., Asito A.S., Sumba P.O., et al. Early age at time of primary Epstein-Barr virus infection results in poorly controlled viral infection in infants from Western Kenya: clues to the etiology of endemic Burkitt lymphoma. J Infect Dis 2012, 205(6):906-913. [Epub 2012 Feb 1].
74. Ptaschinski C., Rochford R. Infection of neonates with murine gammaherpesvirus 68 results in enhanced viral persistence in lungs and absence of infectious mononucleosis syndrome. J Gen Virol 2008, 89(Pt 5):1114-1121.
75. Niederman J.C., McCollum R.W., Henle G., et al. Infectious mononucleosis-clinical manifestations in relation to EB virus antibodies. JAMA 1968, 203:205-209.
76. Epstein M.A., Achong B.G., Henle W., et al. The virus as the etiologic agent of infectious mononucleosis. The Epstein-Barr virus 1979, 279-320. Springer-Verlag, Berlin, Heidelberg, New York. M.A. Epstein, B.G. Achong (Eds.).
77. Dan R., Chang R.S. A prospective study of primary Epstein-Barr virus infections among university students in Hong Kong. Am J Trop Med Hyg 1990, 42:380-385.
78. Sawyer R.N., Evans A.S., Niederman J.C., et al. Prospective studies of a group of Yale University freshmen. I. Occurrence of infectious mononucleosis. J Infec Dis 1971, 123:263-270.
79. Portal-Celhay C., Perez-Perez G.I. Immune responses to Helicobacter pylori colonization: mechanisms and clinical outcomes. Clin Sci (Lond) 2006, 110(3):305-314. [Review].
80. Stray-Pedersen A., Gaustad P., Stray-Pedersen B., Rognum T.O. Detection rate of Helicobacter pylori stool antigen in newborn infants and small children. J Perinat Med 2007, 35(2):155-158.
81. Arnold I.C., Lee J.Y., Amieva M.R., et al. Tolerance rather than immunity protects from Helicobacter pylori-induced gastric preneoplasia. Gastroenterology 2011, 140(1):199-209. [Epub 2010 Jun 22].
82. Thun M.J., DeLancey J.O., Center M.M., Jemal A., Ward E.M. The global burden of cancer: priorities for prevention. Carcinogenesis 2010, 31(1):100-110. [Epub 2009 Nov 24].
83. Simmonds P. The origin and evolution of hepatitis viruses in humans. J Gen Virol 2001, 82(Pt 4):693-712. [Review].
84. Forster P., Torroni A., Renfrew C., Röhl A. Phylogenetic star contraction applied to Asian and Papuan mtDNA evolution. Mol Biol Evol 2001, 18(10):1864-1881.
85. Terrenato L., Shrestha S., Dixit K.A., et al. Decreased malaria morbidity in the Tharu people compared to sympatric populations in Nepal. Ann Trop Med Parasitol 1988, 82(1):1-11.
86. Fornarino S., Pala M., Battaglia V., et al. Mitochondrial and Y-chromosome diversity of the Tharus (Nepal): a reservoir of genetic variation. BMC Evol Biol 2009, 2(9):154.
87. Blench R. The world turned upside down: sago-palm processors in Northeast India and the origins of Chinese civilization. Internet article: http://www.rogerblench.info/Archaeology/SE%20Asia/Dublin%202012/EURASEAA%2014%20paper%20Blench%20NE%20India.pdf.
88. Franklin B.S., Ishizaka S.T., Lamphier M., et al. Therapeutical targeting of nucleic acid-sensing Toll-like receptors prevents experimental cerebral malaria. Proc Natl Acad Sci USA 2011, 108(9):3689-3694. [Epub 2011 Feb 8].
89. Arama C., Giusti P., Boström S., et al. Interethnic differences in antigen-presenting cell activation and TLR responses in Malian children during Plasmodium falciparum malaria. PLoS One 2011, 6(3):e18319.
90. Ockenhouse C.F., Hu W.C., Kester K.E., et al. Common and divergent immune response signaling pathways discovered in peripheral blood mononuclear cell gene expression patterns in presymptomatic and clinically apparent malaria. Infect Immun 2006, 74(10):5561-5573.
91. Barreiro L.B., Ben-Ali M., Quach H., Laval G., Patin E., Pickrell J.K., et al. Evolutionary dynamics of human Toll-like receptors and their different contributions to host defense. PLoS Genet 2009, 5(7):e1000562. [Epub 2009 Jul 17].
92. Judson F.N., Lince D.M., Anders B.J., et al. Health status of Southeast Asian refugees. West J Med 1984, 141(2):183-188.
93. Mitchell H.M., Li Y.Y., Hu P.J., et al. Epidemiology of Helicobacter pylori in southern China: identification of early childhood as the critical period for acquisition. J Infect Dis 1992, 166(1):149-153.
94. Tsai W.S., Chang M.H., Chen J.Y., Lee C.Y., Liu Y.G. Seroepidemiological study of Epstein-Barr virus infection in children in Taipei. Zhonghua Min Guo Xiao Er Ke Yi Xue Hui Za Zhi 1989, 30(2):81-86.
95. Hong Kong Cancer Registry, Hong Kong Cancer Stat 2007. Hospital Authority, 2009.
96. Gagneux S., DeRiemer K., Van T., et al. Variable host-pathogen compatibility in Mycobacterium tuberculosis. Proc Natl Acad Sci USA 2006, 103(8):2869-2873. [Epub 2006 Feb 13].
97. Zerjal T., Xue Y., Bertorelle G., et al. The genetic legacy of the Mongols. Am J Hum Genet 2003, 72(3):717-721. [Epub 2003 Jan 17].
98. Breurec S., Guillard B., Hem S., et al. Evolutionary history of Helicobacter pylori sequences reflect past human migrations in Southeast Asia. PLoS One 2011, 6(7):e22058. [Epub 2011 Jul 19].
99. Yamaoka Y., Kato M., Asaka M. Geographic differences in gastric cancer incidence can be explained by differences between Helicobacter pylori strains. Intern Med 2008, 47(12):1077-1083. [Epub 2008 Jun 16. Review].
100. Kawai M., Furuta Y., Yahara K., et al. Evolution in an oncogenic bacterial species with extreme genome plasticity: Helicobacter pylori East Asian genomes. BMC Microbiol 2011, 16(11):104.
101. Miwa H., Go M.F., Sato N. H. pylori and gastric cancer: the Asian enigma. Am J Gastroenterol 2002, 97(5):1106-1112. [Review].
102. Kramvis A., Kew M., François G. Hepatitis B virus genotypes. Vaccine 2005, 23(19):2409-2423. [Review].
103. Liu S., Zhang H., Gu C., et al. Associations between hepatitis B virus mutations and the risk of hepatocellular carcinoma: a meta-analysis. J Natl Cancer Inst 2009, 101(15):1066-1082. [Epub 2009 Jul 2].
104. Data from World Bank. Internet website: http://data.worldbank.org/country.
105. Global tuberculosis control: WHO report 2011. Internet website: http://www.who.int/tb/publications/global_report/en/.
106. Genc M.R., Vardhana S., Delaney M.L., et al. Relationship between a toll-like receptor-4 gene polymorphism, bacterial vaginosis-related flora and vaginal cytokine responses in pregnant women. Eur J Obstet Gynecol Reprod Biol. 2004, 116(2):152-156.